CVS Company Profile and Key Details

CVS Health Corp. trades at a P/E ratio of 24.36, slightly below the S&P 500 average, with a price-to-sales ratio of 0.29 and a price-to-book ratio of 1.49 suggesting the stock is closer to book value. The P/FCF stands at 10.12, also above market averages.

CVS Health Corp. last paid a dividend of 2.66 per share, this equals a trailing yield of roughly 4.26%. Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $263.69. This means the shares are trading below this model’s fair value.

CVS Health Corp. has 1.28 billion shares outstanding. The public float is 1.27 billion shares, elevated short interest at 1.54% of float. This equals 19.52 million shares. The short ratio is 2.47 days. Institutional investors hold 90.23% of the float. Insiders own 0.06%. Moriarty Thomas M holds 608.13 thousand shares, MERLO LARRY J has 524.03 thousand shares and Lynch Karen S has 431.39 thousand shares. Over the past six months, insider transactions show net selling. They sold 448.50 thousand shares across 4 transactions.

CVS Health Corp. generated EPS of $1.38 over the past year. Five-year average earnings growth is -23.94%. Wall Street analysts project EPS growth of 11.83% annually over the next five years. The latest quarter delivered EPS of $2.58. The next quarter is forecast at $2.23. Next year's EPS is expected at -$0.80. Analyst sentiment is bullish. Analyst rating data shows there are 32 Strong Buy ratings, 16 Buy ratings, 3 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $123.00 to $77.00. The high target offers 32.23% upside. The low target suggests -17.22% downside. The mean target is $100.29. This offers 7.82% upside. CVS Health Corp. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended August 05, 2026, missed forecasts by 37.97%. The prior quarter beat by 17.89%. Over the last six quarters, Apple has recorded several small beats. These include 32.35% in May 01, 2025.

CVS Health Corp. (NYSE:CVS) shares are flat 0.92% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows CVS Health Corp. trading at a premium to the broader market with a P/E of 24.36. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $90.01, suggesting -3.24% downside. Our AI forecast model points to short-term weakness (-7.41% over two weeks), a medium-term fall (-37.31% over three months), and a longer-term gain (9.12% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that CVS Health Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -7.41%, with price expected at $86.13 by September 03, 2026, within a range of $83.59 to $88.99 3-Month Outlook: Projected fall of -37.31%, reaching $58.31 by November 18, 2026, with a range of $51.24 to $62.73. 1-Year Outlook: Projected gain of 9.12%, with price at $101.50 by August 20, 2027, within a range of $97.21 to $105.63.